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PPP3CB instead of PPP3CA, probably due to the unique 
proline-rich region present in the N-terminus of PPP3CB, 
which controls the specificity of its interaction partners. Fur-
thermore, we show that inhibition of the interaction with cal-
cineurin inhibitor, cyclosporin A (CsA), leads to the retention 
of ATOH8 to the cytoplasm, suggesting that the interaction 
renders nuclear localization of ATOH8 which may be critical 
to control its activity as transcription factor.
Keywords ATOH8 · PPP3CB · Calcineurin ·  
Cyclosporin A
Introduction
ATOH8 is a basic helix-loop-helix (bHLH) transcription 
factor (Chen et al. 2011), involved in various developmen-
tal programs such as neurogenesis (Inoue et al. 2001; Yao 
et al. 2010), differentiation of pancreatic precursor cells 
(Lynn et al. 2008) podocytes (Ross et al. 2006), muscle 
development (Yao et al. 2010; Balakrishnan-Renuka et al. 
2014), differentiation of endothelial cells (Fang et al. 2014) 
and muscle fiber regeneration (Guttsches et al. 2015). 
Atoh8 has recently also been identified as a novel onco-
gene candidate as it shows abnormal DNA copy number 
in glioblastoma multiforme (Freire et al. 2008). In mouse, 
it is expressed widespread in various types of tissues and 
organs, suggesting its multiple roles in different cellu-
lar contexts (Wang et al. 2015). It is proposed that Atoh8 
expression may be regulated by tissue-specific bHLH tran-
scription factors in different cellular contexts so that it 
can play exclusive roles in different developmental events 
(Pujadas et al. 2011). The viability of mice deficient in 
this gene depends on the knockout regions ranging from 
early embryonic death (Lynn et al. 2008) to survival into 
Abstract ATOH8 is a bHLH transcription factor playing 
roles in a variety of developmental processes such as neuro-
genesis, differentiation of pancreatic precursor cells, develop-
ment of kidney and muscle, and differentiation of endothelial 
cells. PPP3CB belongs to the catalytic subunit of the serine/
threonine phosphatase, calcineurin, which can dephosphoryl-
ate its substrate proteins to regulate their physiological activi-
ties. In our study, we demonstrated that ATOH8 interacts with 
PPP3CB in vitro with different approaches. We show that the 
conserved catalytic domain of PPP3CB interacts with both 
the N-terminus and the bHLH domain of ATOH8. Although 
the interaction domain of PPP3CB is conserved among all 
isoforms of calcineurin A, ATOH8 selectively interacts with 
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adulthood (Rawnsley et al. 2013). Recent studies start 
revealing the molecular mechanism how ATOH8 regulates 
different developmental events: In pancreatic mPAC cells, 
ATOH8 acts as a Neurogenin repressor and its repres-
sion activity could probably be attributed to its binding to 
E47 protein, which may inhibit the activity of E47/E47 or 
E47/Neurogenin3 dimer (Ejarque et al. 2013). Reporter 
assays show that ATOH8 lacks a transactivation domain 
and possesses intrinsic repressor activity that depends on 
a conserved Proline-rich domain (Ejarque et al. 2013). In 
zebrafish, ATOH8 is required during heart development and 
it genetically interacts with heart transcriptional regula-
tors GATA4 and FOG1. Furthermore, it could form a pro-
tein complex with GATA4 and FOG2 in vitro (Rawnsley 
et al. 2013). During differentiation of hESC to endothelial 
cells, ATOH8 directly targets the promoter of an endothe-
lial marker, eNOS, to regulate its expression (Fang et al. 
2014). As an iron-regulation transcription factor (Kautz 
et al. 2008), ATOH8 is also shown to directly bind to the 
promoter of Hmap, which is involved in the maintenance of 
iron homeostasis (Patel et al. 2014).
PPP3CB is one of the three isoforms of the A subunit 
of calcineurin (CnA). Calcineurin is a calcium-dependent 
serine/threonine phosphatase. It consists of two subunits: 
subunit A (CnA) and subunit B (CnB). CnA comprises a 
catalytic domain followed by a B subunit regulatory site 
(Sikkink et al. 1995), a calmodulin binding site (Kincaid 
et al. 1988) and an inhibitory domain (Hashimoto et al. 
1990). The last three regions constitute the regulatory 
region of CnA. Removal of the last two regions converts 
CnA to a constitutively active phosphatase independent of 
the calcium signal (Kim et al. 2009; Molkentin et al. 1998). 
The B subunit (CnB) is the regulatory subunit, which binds 
to calcium, stabilizes the protein complex and promotes the 
binding of calmodulin to CnA. Therefore as a mediator of 
calcium signaling, calcineurin translates the calcium signal 
into direct dephosphorylation of a number of target proteins 
including transcription factors, ion channels, apoptosis fac-
tors, cytoskeleton proteins and others (Li et al. 2011). For 
example, the family of transcription factors termed NFATs 
(nuclear factor of activated T cells) could be translocated 
from the cytoplasm into the nucleus to act as a functional 
transcription factors after dephosphorylation by calcineurin 
(Beals et al. 1997); phosphate groups of Tau protein have 
also been shown to be removed by calcineurin to prevent 
the aggregation of the protein in the brain (Gong et al. 
1994).
For CnA, three isoforms PPP3CA (CnAα), PPP3CB 
(CnAβ) and PPP3CC (CnAγ) have been identified. Both 
α and β isoforms are expressed ubiquitously while γ is 
found to be present in testis and brain (Perrino et al. 2002). 
In spite of the overlapping expression of α and β isoforms 
in various tissues, it is proposed that they have distinct 
physiological roles as corroborated by various evidence: 
CnAα mutant mice have a smaller size and survive only a 
few weeks, while CnAβ mutant mice are able to live longer 
and are fertile (Gooch et al. 2004). CnAα plays exclusive 
roles in antigen-specific T cell response (Zhang et al. 1996) 
and kidney development (Gooch et al. 2004), while the β 
isoform is required for the T cell development and survival 
(Manicassamy et al. 2008). The distinct roles of CnAα and 
CnAβ in different tissues may be due to the differences in 
substrate selection (Perrino et al. 2002). In addition, the 
expression of the β isoform is specifically upregulated in 
the Alzheimer’s disease (AD) brain, suggesting a critical 
role of the β isoform during the pathogenesis of AD (Hata 
et al. 2001). Finally, the γ isoform was found to be associ-
ated with schizophrenia (Sacchetti et al. 2013).
In our study, we focus on the β isoform of calcineurin, 
PPP3CB, and demonstrate for the first time that ATOH8 
interacts with PPP3CB and identify the regions of interac-
tion in both proteins. While the conserved catalytic domain 
of calcineurin A is responsible for the direct interaction, the 
regulatory regions, especially the unique proline-repeats in 
the N-terminus of PPP3CB, seem to contribute to the selec-
tivity of substrate partners, as PPP3CB but not PPP3CA 
has affinity to ATOH8 in spite of their conserved catalytic 
domain. Functionally, our results showed that calcineurin 
mediates ATOH8 nuclear translocation from cytoplasm, 
as ATOH8 remained in the cytoplasm after inhibiting cal-
cineurin with CsA, revealing a potential new mechanism 
how the transcriptional activity of ATOH8 could be con-
trolled by calcineurin-mediated calcium signaling.
Results
Primary structure of human ATOH8 and PPP3CB
Sequence analysis of human ATOH8 (NP_116216.2, 
Fig. 1) shows that there is a proline-rich region (PRR) rang-
ing from residue 69 to 187. Within this region, 39 out of 
119 residues are prolines. A serine-rich region (SRR) starts 
from residue 190 and ends at residue 209. It contains 9 
serines out of the 20 residues. Adjacent to the C-terminus 
of the serine-rich region, a predicted nuclear localiza-
tion signal (NLS; P210R211K212R213) is present. A bHLH 
domain spans from Arg231 to Leu285. The basic region 
of the bHLH domain consists of the residues from 231 to 
242, while the HLH domain spans from 243 to 285. At the 
C-terminus of the protein locates another predicted NLS 
(K317K318R319K320).
Sequence alignment of PPP3CB with the other two 
isoforms PPP3CA and PPP3CC shows that all three iso-
forms have the conserved catalytic domain (phosphatase 
domain), a CnB binding site, a calmodulin binding site and 
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an inhibitory domain (Fig. 1). In contrast to PPP3CA and 
PPP3CC, there is a proline repeat (from residue 11 to 21) 
unique to PPP3CB (Fig. 1).
Interaction between PPP3CB and ATOH8
Initially, the interaction between PPP3CB and ATOH8 was 
discovered from a yeast-2-hybrid screen (data not shown). 
To examine the possibility of their interaction in mamma-
lian cells, we first investigated whether they co-localize or 
not in two different cell lines, HEK293 and C2C12. The 
results showed that they indeed co-localized in the cyto-
plasm of the cells from these two lines (Fig. 2). To con-
firm the interaction, we performed fluorescence resonance 
energy transfer (FRET) experiments. We ectopically 
expressed ECFP-EYFP fusion protein in HEK293 cells 
as positive control, ECFP and EYFP-PPP3CB fusion pro-
tein as negative control, and ATOH8-ECFP fusion protein 
paired with EYFP-PPP3CB fusion protein for FRET exam-
ination. We selected those cells where ECFP and EYFP 
co-localize in the cytoplasm for FRET analysis. The results 
showed that for both positive control and the pair (ATOH8-
ECFP and EYFP-PPP3CB), FRET occurred in the exam-
ined region of interest (ROI), as CFP intensity increased 
after bleaching YFP (Fig. 3a, c). For negative control, CFP 
intensity decreased after bleaching YFP in the examined 
ROI (Fig. 3b).
The interaction between ATOH8 and PPP3CB could be 
corroborated by our pulldown experiments. We enriched 
the GST-PPP3CB fusion protein and incubated GST-
PPP3CB with mammalian cell lysates containing overex-
pressed ATOH8-ECFP fusion protein. The results showed 
that GST-PPP3CB fusion protein (~87KDa) pulled down 
ATOH8-ECFP (~61KDa), while it did not show any affin-
ity to ECFP (Fig. 4a). Furthermore, GST alone did not pull 
down either ATOH8-ECFP or ECFP (Fig. 4a). Consistently, 
the GST-ATOH8 fusion protein (~61KDa) pulled down 
EYFP-PPP3CB (~ 87KDa) as well (Fig. 4b).
To further verify this interaction in mammalian cells, we 
co-expressed constitutively active PPP3CB (referred to as 
P1-401) and ATOH8-ECFP fusion protein in mammalian 
cells and performed co-immunoprecipitation (Co-IP). The 
results show that ATOH8-ECFP fusion protein is able to 
precipitate the active PPP3CB (~47 kDa; Fig. 5), but not 
the full-length PPP3CB (data not shown).
While the interaction between PPP3CB and ATOH8 was 
confirmed, we were also interested to know whether the 
other two isoforms of calcineurin A, PPP3CA and PPP3CC, 
interact with ATOH8 or not. Our pulldown assay showed 
that there was no affinity between full-length PPP3CA and 
Fig. 1  Primary structure of ATOH8 and PPP3CB. ATOH8 comprises 
a proline-rich region (PRR), a serine-rich region (SRR), a bHLH 
domain and two predicted nuclear localization signal (NLS). PPP3CB 
contains a proline repeat, a catalytic domain, a CnB binding site (CB-
BS), a calmodulin binding site (CBS) and an inhibitory domain (ID). 
The phosphatase domain, CB-BS, CBS and ID are conserved among 
the three isoforms of CnA
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ATOH8 (Fig. 6a). We used isoform 2 (NM_005605.4) of 
PPP3CC for the pulldown experiment and observed that 
overexpression of this isoform caused severe death of Cos7 
cells and produced a truncated protein (data not shown). 
We then tried the experiment in HEK293T cells. Again, cell 
death was observed (data not shown) and only a truncated 
protein of PPP3CC was produced which showed interac-
tion with ATOH8 (Fig. 6b).
In summary, our results from different methods provide 
sufficient evidence that ATOH8 interacts with PPP3CB, 
but not with PPP3CA, while the interaction with PPP3CC 
needs to be further investigated.
Mapping the regions of interaction of ATOH8 
and PPP3CB
To dissect which regions of the two proteins that are 
responsible for the interaction, we first split ATOH8 into 
two parts (A1-230 and A188-321, respectively, Fig. 7) and 
fused them with ECFP, respectively. PPP3CB was divided 
into two parts as well (P1-401 and 355–525, respectively, 
Fig. 7), which were fused with GST. Using the GST fusion 
proteins as baits, we performed pulldown assay again. 
The results showed that both GST-PPP3CB (~87 kDa) 
and GST-(P1-401) (~72 kDa) pulled down ATOH8-ECFP 
(~61 kDa, Fig. 7a), (A1-230)-ECFP (~52 kDa, Fig. 7b) and 
(A188-321)-ECFP (~43 kDa, Fig. 7c). GST-(P355-525) 
did not pull down any prey protein (Fig. 7). In addition, it 
seemed that P1-401 had a stronger affinity to ATOH8 than 
the full-length PPP3CB, as shown by more intensive bands 
detected by EGFP antibody (Fig. 7).
To further analyze the interaction regions, we 
divided P1-401 into two parts, P1-102 and P81-401, 
and fused them with GST, respectively. As both A1-230 
and A188-232 showed affinity with PPP3CB, we thus 
split ATOH8 into A1-190, A118-230 and A225-321 
and fused them with ECFP. Our data clearly show that 
GST-(P81-401) pulled down both A1-190 (~48 kDa, 
Fig. 8a) and A225-321 (~39 kDa, Fig. 8c), but not the 
A118-230 (Fig. 8b).
Subsequent pulldown experiments showed that P81-
401 pulled down A1-92 (~38 kDa, Fig. 9a) and A225-275 
(~34 kDa, Fig. 9d), while A90-190 and A255-321 were not 
pulled down by P81-401 (Fig. 9b, c). Moreover, P81-401 
pulled down A1-55 (~34 kDa, Fig. 10a) rather than A51-92 
(~32 kDa, Fig. 10b). In contrast, the shortened A225-275 
(A239-275) lost the affinity to P81-401 (Fig. 10c).
To sum up, we have narrowed down the interac-
tion regions of both proteins with pulldown assays: For 
PPP3CB, it ranges from residues 81–401 (P81-401), which 
contains the phosphatase domain; for ATOH8, two separate 
interaction regions have been found. One is located in the 
N-terminus of ATOH8 (A1-55), and the other is within the 
bHLH domain (A225-275).
Fig. 2  Co-localization of Atoh8 and PPP3CB in HEK293 and C2C12 
cell lines. a–d In HEK293 cells, Atoh8 is shown in green, PPP3CB 
in red, and the nuclei were counterstained with DAPI in blue. e–h 
Shows the immunohistochemical stainings of ATOH8 (green) and 
PPP3CB (red) in C2C12 cells with the same antibodies used in 
HEK293 cells
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Fig. 3  FRET between ATOH8-
ECFP and EYFP-PPP3CB 
fusion protein. Region of 
interest 1 (ROI 1) is treated 
with YFP bleach. ROI 2 is the 
region without treatment of YFP 
bleach. a FRET of ECFP-EYFP 
fusion protein (positive control 
of FRET). In ROI 1, CFP inten-
sity increases after bleaching 
YFP. In ROI 2, CFP intensity 
remains relatively stable.  
b No FRET between ECFP and 
EYFP-PPP3CB fusion protein 
(negative control of FRET). 
In both ROIs, CFP intensity 
remains relatively stable.  
c FRET between ATOH8-ECFP 
and EYFP-PPP3CB. CFP inten-
sity increases after bleaching 
YFP as shown in ROI 1, while 
in ROI 2, CFP intensity remains 
relatively stable in ROI 2
10 Histochem Cell Biol (2016) 145:5–16
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Inhibiting calcineurin prevents nuclear accumulation 
of ATOH8
After confirming the interaction between ATOH8 and 
PPP3CB, we were interested to know the physiologi-
cal role of this interaction. We hypothesized that PPP3CB 
may affect the subcellular localization of ATOH8 by 
dephosphorylating ATOH8, probably in a way similar to 
the nuclear localization of NFATs mediated by calcineu-
rin. To validate the hypothesis, we inhibited calcineu-
rin with cyclosporin A (CsA), a calcineurin inhibitor, in 
HEK293 cells after ectopically expressing ATOH8. The 
results showed that the ectopically expressed fusion pro-
tein ATOH8-ECFP was retained in the cytoplasm after 
CsA treatment (Fig. 11e–h). In contrast, ATOH8-ECFP 
was majorly localized in the nuclei with DMSO treatment 
(Fig. 11a–d).
Discussion
ATOH8 is a bHLH transcription factor expressed in a vari-
ety of different tissues such as brain, heart, skeletal muscle, 
kidney and pancreas (Lynn et al. 2008; Wang et al. 2015). 
Functional analyses have revealed that it regulates the dif-
ferentiation of neural precursors (Inoue et al. 2001), pan-
creas precursor cells (Lynn et al. 2008) and podocytes (Ross 
et al. 2006) and the development of retina and muscles (Bal-
akrishnan-Renuka et al. 2014; Yao et al. 2010), and other 
tissues. To function as a transcription factor, the nuclear 
localization of the protein is the key in order to bind to the 
target DNA. As seen from the structure of ATOH8, the pro-
tein comprises two predicted sites of NLS, and one of them 
Fig. 4  Pulldown between ATOH8 and PPP3CB. a GST-PPP3CB 
pulls down ATOH8-ECFP. GST-PPP3CB (~87KDa) and GST 
(~26 kDa, control) are the baits. Lysates containing ATOH8-ECFP 
(~61 kDa) and ECFP (~25 kDa, control) are preys. ATOH8-ECFP 
is specifically pulled down by GST-PPP3CB. b GST-ATOH8 pulls 
down EYFP-PPP3CB. GST-ATOH8 (~61 kDa) and GST (~26 kDa, 
control) are the baits. Lysates containing EYFP-PPP3CB (~87 kDa) 
and EYFP (~25 kDa, control) are preys. EYFP-PPP3CB is specifi-
cally pulled down by GST-ATOH8
Fig. 5  Co-immunoprecipitation of ATOH8 and active PPP3CB (P1-
401). P1-401 (~47 kDa) is co-immunoprecipitated with ATOH8-
ECFP (~61 kDa)
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is adjacent with the serine-rich region (SRR). This SRR is 
liable to phosphorylation and dephosphorylation which may 
either mask or expose the neighboring NLS. As a result, the 
cytoplasmic protein could be retained in the cytoplasm or 
shuttled into the nucleus. From our results, we have shown 
that the catalytic subunit of calcineurin, PPP3CB, interacts 
with ATOH8. Assumedly, as a serine/threonine-dependent 
phosphatase, calcineurin may dephosphorylate ATOH8 and 
thus affects its subcellular localization. Indeed, we found 
that ATOH8 nuclear localization was blocked after inhib-
iting calcineurin with CsA. This is reminiscent of NFAT 
nuclear translocation from the cytoplasm (Okamura et al. 
Fig. 6  Full-length PPP3CA shows no affinity to ATOH8. a EYFP-
PPP3CA expressed in Cos7 cells could not be pulled down by GST-
ATOH8, in contrast to the positive control EYFP-PPP3CB. Full-
length EYFP-PPP3CC could not be detected in the input. b Truncated 
PPP3CC interacts with ATOH8. In HEK293 cells, no full-length 
EYFP-PPP3CC is detected. Instead, the truncated EYFP-PPP3CC is 
produced and pulled down by GST-ATOH8. The truncated EYFP-
PPP3CC has a molecular weight of about 70 kDa. Minus the ~27 kDa 
of EYFP, the remaining peptide has a molecular weight of ~43 kDa, 
which is close to that of the catalytic domain of PPP3CC
Fig. 7  P1-401 pulls down ATOH8. a GST-PPP3CB (~87 kDa) and GST-(P1-401; ~72 kDa) pull down ATOH8-ECFP (~61 kDa). b GST-
PPP3CB and GST-(P1-401) pull down (A1-230)-ECFP (~52 kDa). c GST-PPP3CB and GST-(P1-401) pull down (A188-321)-ECFP (~43 kDa)
12 Histochem Cell Biol (2016) 145:5–16
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2000; Beals et al. 1997). In the cytoplasm, SRR of NFAT is 
initially phosphorylated which masks the NLS of the pro-
tein. Upon the activation of calcineurin, it dephosphorylates 
the SRR and exposes the NLS, leading to the translocation 
of NFAT from the cytoplasm to the nucleus (Okamura et al. 
2000). It is highly possible that the subcellular localization 
of ATOH8 is mediated in a similar way by calcineurin, but 
the individual steps remain to be investigated.
The interaction domain of PPP3CB, which is almost 
equivalent to the phosphatase domain, is conserved among 
the three different isoforms of calcineurin A. However, our 
results showed that ATOH8 interacts with PPP3CB, but not 
with PPP3CA. This may be due to the distinct substrate 
preferences of the isoforms in spite of their almost identi-
cal catalytical and regulatory domains (Perrino et al. 2002). 
Furthermore, it has been reported that the proline-rich 
region, which is uniquely present in PPP3CB, is involved in 
specific substrate selection because the affinity of PPP3CB 
to its substrates dramatically decreases after removal of the 
proline-rich region (Kilka et al. 2009). These may explain 
the affinity of ATOH8 to PPP3CB instead of PPP3CA.
At least two different regions of ATOH8 were identi-
fied to interact with PPP3CB. Previous studies showed 
that two conserved motives PxIxIT and LxVP mediate 
the interaction between CnA and its substrate proteins (Li 
et al. 2011). We did not find such motives in these two 
Fig. 8  P81-401 pulls down A1-190 and A225-321. a GST-(P1-401) 
(~72 kDa) and GST-(P81-401) (~64 kDa) pull down (A1-190)-ECFP 
(~48 kDa). b (A188-230)-ECFP (~32 kDa) is not pulled down by any 
bait protein. c GST-(P1-401; ~72 kDa) and GST-(P81-401; ~64 kDa) 
pull down (A25-321)-ECFP (~39 kDa)
Fig. 9  A1-92 and A225-275 are pulled down by P81-401. a, c P81-401 pulls down (A1-92)-ECFP (~38 kDa) and (A225-275)-ECFP (~34 kDa). 
b, d (A90-190)-ECFP (~38 kDa) and (A277-321)-ECFP (~33 kDa) are not pulled down by any bait
13Histochem Cell Biol (2016) 145:5–16 
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regions of ATOH8, suggesting that proteins without the 
two motives could also interact with CnA. In addition, one 
of the interaction regions is located in the bHLH domain. 
As shown by our previous study, bHLH domain of ATOH8 
orthologous is highly conserved among metazoans (Chen 
et al. 2011). And the structure of PPP3CB, especially the 
catalytic domain, is also highly conserved in metazoans. 
Thus the interaction of ATOH8 and PPP3CB mediated by 
Fig. 10  A1-55 is pulled down by P81-401. a P81-401 pulls down (A1-55)-ECFP (~32 kDa) and (A225-275)-ECFP. b, c A51-91 and A239-275 
have no affinity to P81-401
Fig. 11  ATOH8-ECFP fusion protein is retained in the cytoplasm. 
a–d In DMSO-treated HEK293 cells, ATOH8-ECFP fusion protein 
is majorly localized in the nucleus as shown by CFP (b) and GFP 
antibody staining (c). e–h After treatment with 10 μM CsA, ATOH8-
ECFP is retained in the cytoplasm
14 Histochem Cell Biol (2016) 145:5–16
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the two conserved domains could be conserved throughout 
evolution as well. However, another region of interaction is 
located in the N-terminal end of ATOH8, which is less con-
served among vertebrates (Chen et al. 2011). This interac-
tion region may emerge as a regulatory region during evo-
lution and could be responsible for the regulation of extra 
affinity of ATOH8 to PPP3CB.
In summary, we have provided sufficient evidence of 
a novel interaction between ATOH8 and calcineurin and 
identified the regions which are responsible for the interac-
tion. Our results further show that calcineurin mediates the 
subcellular localization of ATOH8, which reveals the regu-




The plasmid constructs for the study were listed in Supple-
mentary Table 1. Most of the plasmids were constructed in 
the PCR-based way. The primers, vectors and cloning sites 
selected were shown in Supplementary Table 1. ATOH8 
(NM_032827.6) cDNA clone was from our previous study 
(Chen et al. 2011). PPP3CB (NM_001142353.2) cDNA 
clone was purchased (Origene). PPP3CA (NM_000944.4) 
cDNA clone was from Addgene (Addgene plasmid 11787); 
cDNA of PPP3CC isoform 2 (NM_005605.4) was cloned by 
RT-PCR. All constructs were verified by Sanger sequencing.
Antibodies
The primary antibodies used in this study included 
ATOH8 antibody (Sigma, AV 39728), PPP3CB anti-
body (Santa Cruz, sc-6124), EGFP antibody (Invitrogen, 
A11122) and GFP antibody JL-8 (Clontech, 632380). 
The secondary antibodies, anti-rabbit (Alexa fluor 488) 
and anti-mouse (Alexa fluor 568 and Alexa fluor 488), 
were used for immunostaining of HEK293 and C2C12 
cell, while HRP-linked anti-rabbit (Sigma, G21234), 
HRP-linked anti-goat (Santa Cruz, SC-2020) were used 
for Western blot. DAPI (invitrogen, D1306) was used for 
nucleus counterstaining.
Cell culture and transfection
HEK293, Cos7 and C2C12 cells were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) with high 
glucose containing 2 mM glutamine supplemented with 
10 % FCS and 1 % penicillin–streptomycin in the incu-
bator of 37 °C and 5 % CO2. HEK 293 cells were trans-
fected with polyethylenimine (PEI) (Polyplus) or MATra 
(IBA). Cos7 cells were transfected with PolyFect (Qia-
gen). Cells were fixed with 4 % PFA/PBS or lysed 48 h 
after transfection.
Fluorescence resonance energy transfer (FRET)
HEK293T cells were cultured on coverslips. Plasmids 
pATOH8-ECFP and pEYFP-PPP3CB were co-transfected 
into HEK293T cells. pECFP-N1 and pEYFP-PPP3CB 
were co-transfected as negative control, respectively, 
pECFP-EYFP as positive control. 48 h after transfection, 
cells were fixed in 4 % PFA/PBS for 30 min and washed 
with PBS. Acceptor photobleach method was used to detect 
FRET under laser confocal scanning microscope (LSM 
510, Zeiss) associated with AIMS software. Firstly 405 
and 515 nm wavelength of laser was used to scan cells to 
select both ECFP and EYFP positive cells. In the selected 
regions of interest, YFP was bleached at 514-nm wave-
length with ten times iterations. Before and after bleaching 
YFP, regions of interest (ROIs) were scanned every 2 s at 
both wavelengths for five times and the real-time intensities 
of CFP and YFP in the ROI were recorded automatically by 
the software in the time window.
Pulldown
GST fusion protein was expressed in BL21 cells and puri-
fied with glutathione beads (Macherey–Nagel) following 
the manual. ECFP or EYFP fusion protein was expressed 
in Cos7 or HEK293T cells, and cell lysate was collected 
to incubate with glutathione beads bound with GST fusion 
protein for 2–4 h at 4 °C on a rotator. Beads were washed 
with lysis buffer for 3–5 times. The protein bound by beads 
was eluted with 50–100 µl 2× Laemmli buffer at 95 °C for 
5–10 min and followed by SDS-PAGE and Western blot.
Co‑immunoprecipitation
Plasmid pairs, pECFP-ATOH8 and pIRES2-dsRed2, 
pECFP-ATOH8 and pIRES2-dsRed2-(P1-401), were co-
transfected into COS7 cells, respectively. 48 h after trans-
fection, cells were lysated with lysis buffer (PBS + 1 % 
Triton 100 + 1× protease inhibitor, 250 mM NaF, 10 mM 
Na3VO4). Lysates were incubated with GFP-trap_A beads 
(Chromotek) for 2 h at 4 °C. Beads were washed with lysis 
buffer for three times. Protein bound with beads was eluted 
with 2× Laemmli buffer and followed by 10 % SDS-PAGE 
and Western blot.
Western blot
Protein samples were boiled in 1× Laemmli buffer at 95 °C 
for 5 min, separated by 10 % SDS-PAGE gel and blotted 
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onto the nitrocellulose membrane. Blotted membranes 
were incubated with proper primary antibodies overnight. 
The membrane was washed with 1× PBST for three times 
and incubated with HRP-conjugated secondary antibod-
ies for 2 h at room temperature. Finally, the protein was 
detected by SuperSignal West Pico Chemiluminescent Sub-
strate (Thermo Scientific, 34077).
Cyclosporin A treatment
HEK293 cells were transfected with pATOH8-ECFP plas-
mid with MATra (IBA). 24 h after transfection, cells were 
treated with 10 µM CsA (Sigma, 30024-25MG) for 24 h. 
For the control, transfected cells were cultured with 0.1 % 
DMSO. After the treatment, the cells were fixed and sub-
jected to immunostaining with JL-8 antibody (Clontech, 
632380) to detect ECFP. All experiments were repeated 
three times.
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